GSWM
ABBV icon

Golden State Wealth Management’s AbbVie ABBV Stock Holding History

Golden State Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7
Closed -$4K – 59
2019
Q3 		$4K Hold
7
– – ﹤0.01% 877
2019
Q2 		$1K Buy
+7
New +$550 ﹤0.01% 1011

Other funds holding ABBV

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Golden State Wealth Management's ABBV Position: Q2 2026 in Review

Golden State Wealth Management increased its AbbVie (ABBV) stake by 1.4% in Q2 2026, buying an estimated $7.96K and bringing the position to 2,747 shares worth $691K. The position accounts for 0.06% of the portfolio, ranked #239.

Golden State Wealth Management first reported a position in ABBV in Q1 2019 and has held it in 19 quarters since. The position peaked at $1.39M in Q4 2021. 2,345 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Golden State Wealth Management held 2,747 shares of AbbVie worth $691K as of Q2 2026.
  • Golden State Wealth Management bought 37 AbbVie shares in Q2 2026, an estimated $7.96K.
  • AbbVie made up 0.06% of Golden State Wealth Management's portfolio in Q2 2026, its #239 holding.
  • Golden State Wealth Management first reported a position in AbbVie in Q1 2019 and has held it in 19 quarters since.
  • Golden State Wealth Management's AbbVie position peaked at $1.39M in Q4 2021.
  • 2,345 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.